ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety of Pioglitazone for Hematoma Resolution In Intracerebral Hemorrhage (SHRINC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00827892
Recruitment Status : Completed
First Posted : January 23, 2009
Last Update Posted : October 2, 2015
Sponsor:
Information provided by (Responsible Party):
Nicole Gonzales, The University of Texas Health Science Center, Houston